Pre-diagnostic statin use, lymph node status and mortality in women with stages I–III breast cancer

BACKGROUND: Recent meta-analyses suggest that pre-diagnostic statin use is associated with reduced breast cancer-specific mortality. Studies have shown that high breast tumour expression of the statin target (3-hydroxy-3-methylglutaryl coenzyme-A reductase) is associated with lymph-node negative can...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Amelia, Murphy, Laura, Zgaga, Lina, Barron, Thomas I, Bennett, Kathleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558692/
https://www.ncbi.nlm.nih.gov/pubmed/28720842
http://dx.doi.org/10.1038/bjc.2017.227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558692/
https://www.ncbi.nlm.nih.gov/pubmed/28720842
http://dx.doi.org/10.1038/bjc.2017.227

Ejemplares similares